Sanofi Ceo On Using Ai To Support Drug Trials

Sanofi CEO on using AI to support drug trials

CNBC Television

Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

Bloomberg Technology

Sanofi CEO Paul Hudson: We have one of the best growth profiles in all of Big Pharma

CNBC Television

Sanofi – Paul Hudson (CEO) introduces Sanofi’s Code of Conduct

Novartis CEO discusses how AI will impact drug development

Sanofi CEO: Dupixent eczema drug is game-changing for the company

CNBC Television

Sanofi chief on new partnership with OpenAI for AI-driven drug development

CNBC Television

CEO Paul Hudson on Sanofi’s Bold New Strategy and “Snackable AI”

Boston Consulting Group

Sanofi races to the AI forefront in Big Pharma; Plus, Medable's big promises for clinical trials

Sanofi – Paul Hudson (Directeur Général) présente la Code de Conduite de Sanofi

How AI is accelerating drug discovery - Nature's Building Blocks | BBC StoryWorks

What's the 'New Sanofi' Like? Let CEO Paul Hudson Explain. | At Barron's

The future of AI in medicine | Conor Judge | TEDxGalway

From Expert AI to Snackable AI: A New Era in Pharma, as Seen by Sanofi’s CEO

DrugPatentWatch

Sanofi – Dermatologist vs. AI: Future of AI and Atopic Dermatitis

Sanofi CEO Paul Hudson Talks AI for BioPharma | Bloomberg Talks

Bloomberg Podcasts

"AI is inverting the pyramid..." | Paul Hudson, CEO at Sanofi

Russell Reynolds Associates

Sanofi CEO on breakthroughs in cancer research, COVID-19 vaccine development, and drug pricing

Sanofi – Nature’s Building Blocks: Finding Hope in Inclusive Clinical Trials

Sanofi – Partner Spotlight: Owkin and Sanofi Embrace the “Golden Era” of Precision Medicine with AI